Geovax Labs Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.26

-0.04 (-3.08%)

As of May 16, 2:34 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 80%

Hold 2 20%

Sell 0 0%

Price Target

Analyst Price Target +1,223.0% upside

Low Target $13.69

Average Target $16.67

High Target $25.88

Current Price $1.26

Current
$1.26

Target
$16.67

$13.69 $16.67 avg $25.88

Scenario Analysis

Bear Case

$13.69

986.5%

Low target

Base Case

$16.67

+1,223.0%

Avg target

Bull Case

$25.88

+1,954.0%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$34.75

-96.4% from high

52-Week Low

$0.96

+30.8% from low

Target vs 52W High

$16.67

-52.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%